Press release
United States Point-of-Care Lipid Test Market to Reach USD 1.23 Billion by 2033, Driven by Preventive Healthcare and Rapid Testing Demand | DataM Intelligence
The global Point-of-Care Lipid Test Market reached USD 0.72 billion in 2024 and is projected to reach USD 1.23 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033, according to DataM Intelligence.United States: Recent Industry Developments
✅ In October 2025, Abbott Laboratories received FDA clearance for its new rapid lipid panel test providing results in under 5 minutes.
✅ In October 2025, The American Heart Association updated guidelines recommending routine point-of-care lipid testing in primary care settings.
✅ In October 2025, A major US retail pharmacy chain implemented lipid testing stations in 2,000 locations, increasing patient access to cardiovascular screening.
Japan: Recent Industry Developments
✅ In October 2025, Roche Diagnostics launched a compact lipid testing device with cloud connectivity for remote patient monitoring.
✅ In October 2025, Japan's Ministry of Health approved point-of-care lipid testing for workplace health screenings nationwide.
✅ In October 2025, Sysmex Corporation developed a multi-parameter testing system integrating lipid profiles with other cardiovascular risk markers.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/point-of-care-poc-lipid-test-market?jd
Market Trends & Drivers
The Point-of-Care Lipid Test Market is experiencing significant growth driven by the rising prevalence of cardiovascular diseases, increasing focus on preventive healthcare, and technological advancements in rapid testing. Key trends include the development of multi-parameter testing devices, integration with electronic health records, and expansion into non-traditional healthcare settings. The growing emphasis on early cardiovascular risk detection, convenience of rapid results, and rising healthcare consumerism are significantly accelerating market adoption across various care settings.
Competitive Landscape
The market features strong competition among diagnostic companies and medical device manufacturers specializing in rapid testing technologies.
Abbott Laboratories leads with its Afinion and i-STAT systems for rapid lipid profiling and cardiovascular risk assessment.
Roche Diagnostics offers the Cobas h 232 system and other POC solutions for lipid testing and cardiac risk management.
Siemens Healthineers provides rapid lipid testing through its DCA Vantage and epoc blood analysis systems.
Quest Diagnostics expands its POC offerings with rapid lipid testing services in retail and workplace settings.
PTS Diagnostics specializes in CardioChek and other point-of-care lipid testing devices for professional and consumer use.
Beckman Coulter, Inc. (Danaher) develops rapid testing solutions for lipid profiles and cardiovascular risk assessment.
Alere Inc. (Abbott) offers rapid lipid testing technologies for various healthcare settings and applications.
Instrumentation Laboratory provides point-of-care testing solutions including lipid profile analysis.
Nova Biomedical develops whole blood analyzers with lipid testing capabilities for point-of-care settings.
ACON Laboratories, Inc. manufactures rapid test strips and readers for cholesterol and lipid panel testing.
Segmentation
By Product Type (Instruments, Consumables)
By Disease Indication (Hyperlipidemia, Hypercholesterolaemia, Tangier Disease, Hyperlipoproteinemia, Familial Hypercholesterolemia, Others)
By Application (Research and Development, Diagnostics, Biotechnological Product Manufacturing, Agriculture, Others)
By End-User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs), Diagnostic Laboratories & Clinical Research Centers, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/point-of-care-lipid-test-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Point-of-Care Lipid Test Market to Reach USD 1.23 Billion by 2033, Driven by Preventive Healthcare and Rapid Testing Demand | DataM Intelligence here
News-ID: 4232548 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP

United States Tequila Industry Sector Startups Gain Funding | Focus on Premium B …
Tequila Market reached US$ 10.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 16.1 billion by 2031. The market is growing at a CAGR of 5.5% during the forecast period 2024-2031
DataM Intelligence has published a new research report on "Tequila Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of…

United States Platinum Group Metals (PGMs) Market 2025 | Global Jewelry Demand & …
DataM Intelligence has published a new research report on "Platinum Group Metals Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
The European Union is set to enforce…

Digital Substation Market 2025: Industry Developments, Future Growth, Share & In …
Digital Substation Market is estimated to grow at a CAGR of 7.5% during the forecast period 2024-2031.
Top Key Players:
Key players are ABB, General Electric Company, Siemens AG, Eaton Corporation Inc., Schneider Electric SE, Honeywell International Inc., Cisco System, NR Electric Co. Ltd., Emerson Electric Co., Larsen & Toubro Limited, Hitachi Energy Ltd.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) :- https://www.datamintelligence.com/download-sample/digital-substation-market?sg
✅ United States -…

United States Pressure Ulcer Devices Market to Reach USD 7.39 Billion by 2033, L …
The global Pressure Ulcer Devices Market reached USD 4.11 Billion in 2024 and is projected to reach USD 7.39 Billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Smith & Nephew launched a new smart wound dressing with integrated pressure sensors for real-time ulcer monitoring.
✅ In October 2025, The Centers for Medicare &…
More Releases for Lipid
Key Trends Shaping the Future Lipid Market From 2025-2034: Advancements In Scala …
What industry-specific factors are fueling the growth of the lipid market?
The lipid market's expansion is projected to be fuelled by a growing demand for nutritional supplements. The increase in nutritional requirements resulting from a more active lifestyle or health condition is often met with supplementation. Lipid-based nutrient supplements - those where lipids supply the majority of the energy and also encompass protein, energy, essential fatty acids, and micronutrients - play…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Lipid Regulators Market Report 2024 - Lipid Regulators Market Trends And Growth
"The Business Research Company recently released a comprehensive report on the Global Lipid Regulators Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Lipid Research: Creative Biolabs Launches Its Lipid-Based Delivery Solutions
Creative Biolabs, a leading biotechnology company, unveiled its latest solutions for developing lipid-based delivery systems last week.
New York, USA - April 18, 2024 - "Liposomes as excellent drug delivery vehicles continuously drive innovation in drug delivery development and open up new breakthroughs and possibilities. Building on this momentum, we have designed a suite of solutions for lipid-based delivery system development," said an expert from the Lipid Research Department, Creative Biolabs.
Image:…
Creative Biolabs: Unlocking Lipid Biology With Complete Lipid Analysis Solutions
Creative Biolabs, a pioneer in the field of biotechnology, is delighted to announce the launch of cutting-edge assay and analysis solutions tailored specifically for liposome drug delivery.
New York, USA - March 26, 2024 - Liposomes, versatile lipid-based structures, have emerged as promising carriers for drug delivery due to their biocompatibility, flexibility, and capacity to encapsulate a wide range of therapeutics. To ensure the successful development of lipid-based drug delivery systems,…
Lipid Nanoparticles (LNP) Market Growth Is Attributed To The Increasing Demand F …
According to Precision Business Insights (PBI) latest report, the Lipid Nanoparticles (LNP) Market size is expected to be worth USD 675.0 Million in 2022, growing at a 7.5% CAGR from 2022 to 2028. The growing demand for therapeutic drugs and vaccinations to combat viral illnesses like Ebola, influenza, HIV, and other viruses, together with the traditional vaccine approach's failure to find vaccines in time for a crisis, are all contributing…